TR199900733T2 - Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlarin tedavisi için bir ilacin imalatinda mupirosin kullanimi. - Google Patents

Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlarin tedavisi için bir ilacin imalatinda mupirosin kullanimi.

Info

Publication number
TR199900733T2
TR199900733T2 TR1999/00733T TR9900733T TR199900733T2 TR 199900733 T2 TR199900733 T2 TR 199900733T2 TR 1999/00733 T TR1999/00733 T TR 1999/00733T TR 9900733 T TR9900733 T TR 9900733T TR 199900733 T2 TR199900733 T2 TR 199900733T2
Authority
TR
Turkey
Prior art keywords
mupirocin
nasopharynx
treatment
colonization
medicament
Prior art date
Application number
TR1999/00733T
Other languages
English (en)
Inventor
Timothy Henkel John
Anthony Hatton Guy
Regina Teresita Tallon Gerandine
Hugh Scott Purdie
Jane Hilton Elizabet
Original Assignee
Smithkline Beecham Corporation
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9716805.8A external-priority patent/GB9716805D0/en
Priority claimed from GBGB9719203.3A external-priority patent/GB9719203D0/en
Application filed by Smithkline Beecham Corporation, Smithkline Beecham P.L.C. filed Critical Smithkline Beecham Corporation
Publication of TR199900733T2 publication Critical patent/TR199900733T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mupirosin veya bunun tuz veya esteri, özellikle de nazofarenkse uygulanmak üzere uyarlanmis olan yeni bir sprey veya terkipleri ile nükseden sinüzit ve nükseden otitin tedavisi için kullanilabilir.
TR1999/00733T 1996-10-01 1997-09-29 Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlarin tedavisi için bir ilacin imalatinda mupirosin kullanimi. TR199900733T2 (tr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2722296P 1996-10-01 1996-10-01
US2722496P 1996-10-01 1996-10-01
US2722396P 1996-10-01 1996-10-01
GBGB9716805.8A GB9716805D0 (en) 1997-08-09 1997-08-09 Novel composition and use
GBGB9719203.3A GB9719203D0 (en) 1997-09-11 1997-09-11 Novel composition and use

Publications (1)

Publication Number Publication Date
TR199900733T2 true TR199900733T2 (tr) 1999-07-21

Family

ID=27517419

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00733T TR199900733T2 (tr) 1996-10-01 1997-09-29 Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlarin tedavisi için bir ilacin imalatinda mupirosin kullanimi.

Country Status (17)

Country Link
US (1) US6001870A (tr)
EP (1) EP0939631A1 (tr)
JP (1) JP2001504091A (tr)
KR (1) KR20000048812A (tr)
CN (1) CN1239427A (tr)
AR (1) AR010995A1 (tr)
AU (1) AU724070B2 (tr)
BR (1) BR9711843A (tr)
CA (1) CA2267248A1 (tr)
CZ (1) CZ112499A3 (tr)
HU (1) HUP9904308A3 (tr)
IL (1) IL129237A0 (tr)
NO (1) NO991548L (tr)
NZ (1) NZ334913A (tr)
PL (1) PL332642A1 (tr)
TR (1) TR199900733T2 (tr)
WO (1) WO1998014189A1 (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1998014189A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
WO1999007341A1 (en) * 1997-08-09 1999-02-18 Smithkline Beecham Plc Compositions for nasal administration
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
GB9902138D0 (en) 1999-02-02 1999-03-24 Smithkline Beecham Container
HRP20010576A2 (en) * 1999-02-03 2002-08-31 Biogal Gyogyszergyar Process for the preparation of pseudomonic acid a antibiotic by microbiological method
WO2000074651A1 (de) * 1999-06-02 2000-12-14 Hexal Ag Pharmazeutische zusammensetzung zur nasalen anwendung von wasserunlöslichen und/oder schwer wasserlöslichen wirkstoffen
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
EP1409703A4 (en) * 2001-06-21 2004-08-18 Biogal Gyogyszergyar METABOLICALLY CONTROLLED FERMENTATION PROCESS FOR THE PRODUCTION OF PSEUDOMONIC ACID
HRP20040642A2 (en) 2001-12-28 2005-10-31 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Processes for preparing crystalline and amorphous mupirocin calcium
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug
JP2008533048A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
EP2497460A1 (en) 2005-03-10 2012-09-12 3M Innovative Properties Co. Methods of reducing microbial contamination
KR20070113281A (ko) 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US20070264296A1 (en) 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US8784790B2 (en) 2008-06-12 2014-07-22 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US20100021563A1 (en) * 2008-07-24 2010-01-28 Paul Levesque Compositions comprising coconut oil and methods of use thereof
US20100086576A1 (en) 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
CN1102410C (zh) * 1993-10-22 2003-03-05 史密丝克莱恩比彻姆公司 莫匹罗星钙盐的乳膏组合物
WO1998014189A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Also Published As

Publication number Publication date
NZ334913A (en) 2001-03-30
JP2001504091A (ja) 2001-03-27
HUP9904308A3 (en) 2002-06-28
EP0939631A1 (en) 1999-09-08
HUP9904308A2 (hu) 2001-04-28
WO1998014189A1 (en) 1998-04-09
NO991548L (no) 1999-03-31
BR9711843A (pt) 2001-07-31
PL332642A1 (en) 1999-09-27
NO991548D0 (no) 1999-03-30
CN1239427A (zh) 1999-12-22
CA2267248A1 (en) 1998-04-09
AU4562397A (en) 1998-04-24
AU724070B2 (en) 2000-09-14
US6001870A (en) 1999-12-14
AR010995A1 (es) 2000-08-02
CZ112499A3 (cs) 1999-08-11
IL129237A0 (en) 2000-02-17
KR20000048812A (ko) 2000-07-25

Similar Documents

Publication Publication Date Title
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
NO991548D0 (no) Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
AU9536898A (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
DE68917163D1 (de) Antibakterielle Mittel.
ZA9710796B (en) Oxyiminopregnanecarbolactones.
BR9403783A (pt) Uso de uma composição cosmética
DE60331849D1 (de) Antibakterielle wirkstoffe
BRPI0411534A (pt) derivados de lincomicina com atividade antimicrobiana
EE9400415A (et) Immobiliseeritud piimhappebakteritega bioreaktor ja selle kasutamine
DE69615155D1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
PL345452A1 (en) Chemotaxis-inhibiting protein of staphylococcus
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
DE69625910D1 (de) Penamsulfone als beta-laktamase inhibitoren
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
DE69827392D1 (de) Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen
FI951725L (fi) Aminoboronihappojohdannaisia, niiden valmistus ja käyttö synteesivälituotteina
BR0214494A (pt) Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmos
ATE73789T1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
HK1022629A (en) Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
TR199701334T1 (tr) Antibakteriyel antibiyotikler.
IT1269873B (it) Nuovi derivati chinolonici, sintesi ed impiego come farmaci antibatterici